Researchers from Lund University in Sweden have discovered higher levels of immune proteins in the blood before and after an epileptic seizure. The possible biomarkers can be identified using a simple ...
Takeda’s late-phase epilepsy program has failed a key test, chalking up misses on the primary endpoints in pivotal trials in two indications. But the Japanese drugmaker still plans to talk to ...
The University of Utah College of Pharmacy's Anticonvulsant Drug Development (ADD) Program has been awarded a five-year $19.5 million contract renewal with the National Institutes of Health (NIH) to ...
Doctors are testing a promising experimental treatment using stem cells to combat seizures in patients with epilepsy. NBC News’ Dr. Akshay Syal spoke with a trial patient about her experience.
NEW HAVEN, Conn. (KABC) -- Every state has different requirements when it comes to driving with epilepsy. Here in California, patients must be seizure-free for a specific period of time and submit a ...
Noninvasive tests performed in midlife may help identify people who are at risk of late-onset epilepsy (LOE), a new study suggests. New data from the Framingham Heart Study show those who scored ...
AIIMS Delhi has resumed free Therapeutic Drug Monitoring (TDM) tests for epilepsy patients. This initiative reduces financial ...
Autoimmune epilepsy is a newly defined group of conditions characterized by recurrent seizures associated with autoimmunity. Cancer and infections are two potential triggers. Epilepsy is a seizure ...
The diagnosis: The man appeared to be having clonic seizures — repeated jerking movements — in his arm while solving sudoku, ...